Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Miriam Barragán-Usero"'
Autor:
Rebeca Carrión-Marchante, Celia Pinto-Díez, José Ignacio Klett-Mingo, Esther Palacios, Miriam Barragán-Usero, M. Isabel Pérez-Morgado, Manuel Pascual-Mellado, Sonia Alcalá, Laura Ruiz-Cañas, Bruno Sainz, Víctor M. González, M. Elena Martín
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1273 (2023)
Lung cancer is the leading cause of cancer-related death worldwide. Its late diagnosis and consequently poor survival make necessary the search for new therapeutic targets. The mitogen-activated protein kinase (MAPK)-interacting kinase 1 (MNK1) is ov
Externí odkaz:
https://doaj.org/article/bc742b1ea6d945ab905340e02546e4a7
Autor:
José Ignacio Klett-Mingo, Julio Cambronero-Plaza, Celia Pinto-Díez, Miriam Barragán-Usero, María V. T. Lobo, Víctor M. González, M. Elena Martín
Publikováno v:
Proceedings of 7th International Electronic Conference on Medicinal Chemistry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d49d76d5c96f2a48b17e9a0e5a199309
https://doi.org/10.3390/ecmc2021-11473
https://doi.org/10.3390/ecmc2021-11473
Autor:
José Ignacio Klett-Mingo, Celia Pinto-Díez, Julio Cambronero-Plaza, Rebeca Carrión-Marchante, Miriam Barragán-Usero, María Isabel Pérez-Morgado, Eulalia Rodríguez-Martín, Mª Val Toledo-Lobo, Víctor M González, M. Elena Martín
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 227
Lung cancer is one of the leading causes of death worldwide and the most common of all cancer types. Histone acetyltransferase 1 (HAT1) has attracted increasing interest as a potential therapeutic target due to its involvement in multiple pathologies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09531b91f7012336d6bd47020bbb31e8
https://doi.org/10.3390/cancers15010227
https://doi.org/10.3390/cancers15010227